No definition available.
Melanocytic naevi of lower limb, including hip
EFO MESH Endpoint Browser PheWeb
CD2_BENIGN_MELANOCYTIC_LOWERLIMB
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1622 |
4. Check minimum number of eventsNone |
1622 |
5. Include endpointsNone |
1622 |
6. Filter based on genotype QC (FinnGen only) |
1622 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) coxae
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of lower limb, including hip
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of lower limb, including hip
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10634 | 6739 | 3862 |
| Only index persons | 9877 | 6347 | 3530 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.19 | 0.11 |
| Only index persons | 0.20 | 0.23 | 0.13 |
| Median age at first event (years) | |||
| Whole population | 39.83 | 41.13 | 37.49 |
| Only index persons | 41.39 | 42.30 | 39.75 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1622 | 1117 | 505 |
| Unadjusted period prevalence (%) | 0.33 | 0.38 | 0.22 |
| Median age at first event (years) | 51.29 | 48.10 | 58.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1428
- Matched controls
- 14280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
68.8
323.0
622
158
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
4097.7
323.0
1350
48
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.9
218.8
465
607
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
11.2
160.6
325
365
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
9.3
151.1
342
467
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
8.2
93.2
222
313
2167A
ICD-9 Finland
Benign neoplasm of skin, Skin of lower limb, including hip[ALARAAJAN IHON BEN KASV,NAEVUS PIGMENTOSUS]
+∞
85.3
81
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.1
84.4
221
357
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.3
70.1
233
505
L57.0
ICD-10 Finland
Actinic keratosis
5.0
64.6
229
530
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
54.0
56.4
67
13
TQW99
NOMESCO Finland
Other minor procedure on skin
6.5
56.0
153
257
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.2
53.9
328
1207
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
8.6
50.1
113
142
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
21.9
49.7
73
35
XQ845
NOMESCO Finland
Dermatoscopy
14.7
48.1
82
59
XQ848
NOMESCO Finland
Dermatological photography
8.1
45.1
105
139
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
52.8
42.9
51
10
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
21.5
42.1
62
30
9733
FHL
Excision of skin change in operating room or anesthesia
14.2
41.9
72
53
S18
ICPC
Laceration/cut
2.2
40.3
642
3914
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
12.6
39.2
71
59
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
52.7
38.7
46
9
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
8.2
38.0
87
112
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
8.3
37.7
86
110
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
4.5
36.1
135
323
L82
ICD-10 Finland
Seborrhoeic keratosis
2.7
35.3
278
1177
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
10.9
30.6
59
56
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
59.7
30.2
35
6
PJA12
NOMESCO Finland
Sentinel node biopsy
3.3
29.1
157
514
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
67.4
29.0
33
5
D03.5
ICD-10 Finland
Melanoma in situ of trunk
42.1
26.8
33
8
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
18.3
26.7
41
23
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
14.9
25.3
42
29
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
13.4
24.8
43
33
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
16.9
24.1
38
23
127
Kela drug reimbursment
Transplant complication
7.6
24.1
57
78
ZXC50
NOMESCO Finland
Cryotherapy
5.8
22.8
66
119
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
10.5
22.7
44
43
L04AA06
ATC
mycophenolic acid; systemic
6.4
22.6
60
97
ZZR00
NOMESCO Finland
Flap of skin
6.9
22.3
56
84
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
15.3
22.0
36
24
S82
ICPC
Naevus/mole
2.4
22.0
208
955
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.7
21.9
64
117
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
31.7
21.5
28
9
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
16.5
21.5
34
21
D22
ICD-10 Finland
Melanocytic naevi
3.5
21.4
105
319
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
8.6
21.2
46
55
Z2221
NOMESCO Finland
Medical doctor
1.8
21.1
432
2721
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
4.8
19.7
66
142
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
3.4
19.2
98
307
SPAT1153
SPAT
Removal of sutures
1.8
18.5
432
2815
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
4.8
18.4
62
134
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.1
17.9
57
116
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
27.1
17.8
24
9
ZZA00
NOMESCO Finland
Split skin graft
4.8
17.5
59
128
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
50.6
17.0
20
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
64.1
16.8
19
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
5.0
16.7
54
112
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.5
16.7
32
31
Z94.0
ICD-10 Finland
Kidney transplant status
7.1
16.5
40
58
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
7.7
16.2
37
49
E0000UV
ATC
NA
1.6
16.1
557
4029
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
16.9
16.1
25
15
ZQZ00
NOMESCO Finland
Treatment of several skin areas
13.7
16.0
27
20
ZXC15
NOMESCO Finland
Use of photodynamic technique
8.6
15.5
33
39
ZXC20
NOMESCO Finland
Use of chemical agents
5.7
15.5
44
79
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
38.5
15.4
19
5
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
8.4
15.3
33
40
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
45.5
15.1
18
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
14.8
524
3792
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
14.6
489
3481
ZXA05
NOMESCO Finland
Left side
1.7
14.2
328
2105
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
7.2
13.8
33
47
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
17.7
13.8
21
12
TQW80
NOMESCO Finland
Local dermatologic skincare
4.2
13.7
52
128
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
6.1
13.5
36
60
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
10.2
13.0
25
25
A11CC03
ATC
alfacalcidol; systemic
4.5
12.7
44
100
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
7.9
12.6
28
36
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
32.3
12.6
16
5
S21
ICPC
Skin texture symptom/complaint
2.0
12.5
175
947
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.4
12.3
44
103
L04AD01
ATC
ciclosporin; systemic
4.4
12.3
44
103
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
14.5
12.3
20
14
B07.9
ICD-10 Finland
Verruca simplex
3.1
12.2
66
218
L04AX01
ATC
azathioprine; systemic
2.7
12.0
82
312
S77
ICPC
Malignant neoplasm of skin
7.6
11.9
27
36
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.5
11.9
41
93
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
16.6
11.7
18
11
J01DB01
ATC
cefalexin; oral
1.6
11.6
1123
9993
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
11.2
11.5
21
19
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
15.2
11.3
18
12
L04AA01
ATC
[U] ciclosporin; systemic
4.6
11.3
38
84
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
35.3
11.3
14
*
C43
ICD-10 Finland
Malignant melanoma of skin
17.2
11.2
17
10
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
14.0
11.0
18
13
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.0
10.9
29
49
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
10.9
345
2390
ZXA00
NOMESCO Finland
Right side
1.6
10.5
330
2280
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
4.5
10.5
36
82
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
16.2
10.4
16
10
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
18.9
10.3
15
8
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
23.5
10.2
14
6
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
6.1
10.0
26
43
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
9.9
70
274
A12AA04
ATC
calcium carbonate; oral
4.9
9.9
31
64
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
16.8
9.9
15
9
DAB00
NOMESCO Finland
Excision of lesion of auricle
8.2
9.8
21
26
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.6
9.7
27
49
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
55.4
9.7
11
*
ZXE00
NOMESCO Finland
One hour or less
1.5
9.6
523
4064
D22.0
ICD-10 Finland
Melanocytic naevi of lip
15.1
9.5
15
10
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
12.4
9.4
16
13
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
8.7
9.3
19
22
L91.0
ICD-10 Finland
Hypertrophic scar
4.7
9.2
30
65
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
7.8
9.1
20
26
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.6
9.1
65
257
137
Kela drug reimbursment
Uraemia requiring dialysis
6.3
9.1
23
37
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
3.4
9.1
43
131
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
9.0
231
1509
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.5
8.9
25
46
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.1
8.8
47
157
QDE15
NOMESCO Finland
Excision of other superficial lesion of skin in lower limb
50.3
8.7
10
*
Z3231
NOMESCO Finland
Registered nurse
1.5
8.5
347
2527
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
6.4
8.5
21
33
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.7
8.4
23
41
D06BB10
ATC
imiquimod; topical
2.4
8.3
70
304
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
8.2
306
2186
5AB14
NOMESCO Finland
NA
17.3
8.1
12
7
L04AA05
ATC
[U] tacrolimus; systemic
17.3
8.1
12
7
TK800
NOMESCO Finland
Hemodialysis
3.7
8.0
33
91
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.9
8.0
46
161
S29
ICPC
Skin symptom/complaint other
1.6
7.9
209
1372
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
13.1
7.9
13
10
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
6.1
7.8
20
33
B03XA02
ATC
darbepoetin alfa; parenteral
4.2
7.8
28
68
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
15.1
7.7
12
8
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
45.2
7.7
9
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
18.5
7.6
11
6
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
6.7
7.6
18
27
B03XA01
ATC
erythropoietin; parenteral
5.8
7.5
20
35
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
7.2
7.5
17
24
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
7.4
244
1692
D06BX02
ATC
ingenol mebutate; topical
5.1
7.4
22
44
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
7.4
494
3941
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
13.4
7.4
12
9
R4110
NOMESCO Finland
Physiotherapy
1.5
7.4
320
2358
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
7.3
7
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
7.2
78
382
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
15.8
7.2
11
7
QBA10
NOMESCO Finland
Incision of skin of trunk
5.5
7.2
20
37
UJF32
NOMESCO Finland
Coloscopy
1.5
7.2
300
2189
QDE00
NOMESCO Finland
Excision of loose skin or fold of skin from lower limb
30.2
7.1
9
*
Z3226
NOMESCO Finland
Physiotherapist
1.5
7.1
221
1512
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.5
7.1
232
1606
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
8.8
7.0
14
16
J02AC01
ATC
fluconazole; systemic
1.4
6.9
548
4483
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.9
6.9
18
31
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.6
6.9
22
48
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.8
6.9
27
72
UJH02
NOMESCO Finland
Anoscopy
2.4
6.8
57
246
Z94.4
ICD-10 Finland
Liver transplant status
8.3
6.8
14
17
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
8.3
6.8
14
17
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.8
450
3573
D18.0
ICD-10 Finland
Haemangioma, any site
2.9
6.8
39
136
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
5.7
6.8
18
32
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
40.2
6.8
8
*
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
40.2
6.8
8
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
16.8
6.7
10
6
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
6.7
87
461
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
6.6
157
1002
S26
ICPC
Fear of cancer of skin
5.2
6.6
19
37
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
6.5
123
738
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
6.5
75
381
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
70.1
6.4
7
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
70.1
6.4
7
*
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
2.9
6.4
35
121
D07XC01
ATC
betamethasone, combinations; topical
1.7
6.3
135
838
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
18.1
6.3
9
5
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
26.8
6.2
8
*
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
26.8
6.2
8
*
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.7
6.2
121
734
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.0
6.2
18
36
ZXA10
NOMESCO Finland
Bilateral
1.5
6.2
220
1550
D07AB08
ATC
desonide; topical
1.7
6.1
127
784
R50.9
ICD-10 Finland
Fever, unspecified
1.6
6.1
164
1083
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
12.6
6.1
10
8
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
6.1
126
775
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
6.1
113
677
N18.0
ICD-10 Finland
End-stage renal disease
4.4
6.0
20
46
D01AE16
ATC
amorolfine; topical
1.7
6.0
129
800
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
6.0
460
3721
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
465
1713
3.40
99.02
1.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
961
5511
2.83
89.63
3.4
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
172
552
3.37
43.49
1.4
1.2
—
—
—
0
0
(4035726)
238
1108
2.35
29.15
1.5
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
37
55
6.86
23.84
24.8
33.2
ug/l
86.3
125.2
3.48
29
47
(3006315) Basophils [#/volume] in Blood
884
6822
1.65
21.18
8.6
5.8
e9/l
0.0
0.0
1.90
782
5953
(3013115) Eosinophils [#/volume] in Blood
906
7059
1.64
20.69
8.7
6.1
e9/l
0.2
0.2
0.18
803
6250
(3001604) Monocytes [#/volume] in Blood
879
6802
1.64
20.59
8.6
5.8
e9/l
0.5
0.6
0.83
780
5930
(3019198) Lymphocytes [#/volume] in Blood
899
7021
1.63
20.08
8.6
5.8
e9/l
1.9
1.9
0.26
812
6228
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
342
2128
1.77
17.94
3.1
2.6
e6/l
2.2
1.0
0.48
210
1187
(3013650) Neutrophils [#/volume] in Blood by Automated count
973
7871
1.59
17.77
11.5
8.9
e9/l
4.0
4.0
0.39
867
6917
(3018095) Leukocytes [#/volume] in Urine
624
4609
1.58
16.55
5.3
3.5
e6/l
74.3
100.4
0.28
434
3188
(42870588) Differential panel, method unspecified - Blood
607
4470
1.57
16.23
8.8
5.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
495
3512
1.59
15.36
4.4
3.0
e6/l
0.2
0.4
2.29
375
2633
(3024561) Albumin [Mass/volume] in Serum or Plasma
707
5440
1.53
15.23
6.8
4.7
g/l
36.7
35.9
3.50
655
5081
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
724
5631
1.52
14.65
2.7
2.3
nmol/l
78.2
76.4
1.10
666
5110
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
788
6293
1.49
13.71
9.0
6.6
mmol/l
1.2
1.2
0.35
678
5339
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1170
10139
1.55
13.68
10.2
7.2
u/l
75.9
77.4
0.65
1109
9549
(3013707) Erythrocyte sedimentation rate by Westergren method
1151
9963
1.53
13.29
5.1
4.0
mm/h
10.4
11.4
2.02
1075
9244
(3018418) pH of Serum or Plasma
508
3727
1.53
13.19
6.7
3.8
ph
7.4
7.4
0.49
80
716
(3002385) Erythrocyte distribution width [Ratio]
1304
11625
1.62
13.10
20.7
15.6
%
13.5
13.6
0.38
1285
11368
(36304419) Bacteria [Presence] in Urine
476
3458
1.53
12.88
4.4
2.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
218
1302
1.78
12.86
7.8
4.0
u/l
225.4
244.2
1.39
210
1239
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
304
1998
1.64
12.61
3.6
2.8
e6/l
3.3
3.0
0.19
172
1065
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
44
5.52
12.60
2.7
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
468
3412
1.52
12.37
9.0
6.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
789
6387
1.46
12.32
9.0
5.9
%
2.8
2.8
0.03
733
5970
(3022096) Basophils/100 leukocytes in Blood
768
6186
1.46
12.30
9.1
5.9
%
0.7
0.7
2.47
714
5795
(3020779) Urea [Moles/volume] in Serum or Plasma
182
1044
1.84
12.25
11.8
7.5
mmol/l
10.1
8.9
1.40
176
1003
(3033658) Prothrombin time (PT) actual/Normal
453
3291
1.52
12.13
5.3
3.7
%
91.4
93.1
0.74
439
3205
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
715
5693
1.46
12.10
7.9
5.9
mmol/l
1.2
1.2
0.43
661
5173
(3011397) Hemoglobin [Presence] in Urine by Test strip
427
3066
1.53
12.06
3.7
3.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
790
6423
1.45
11.90
9.2
6.1
%
8.3
8.4
0.13
738
6044
(3018010) Neutrophils/100 leukocytes in Blood
801
6539
1.44
11.75
8.7
5.7
%
56.9
56.9
0.00
747
6151
(3002030) Lymphocytes/100 leukocytes in Blood
810
6627
1.44
11.74
9.0
5.9
%
28.6
28.6
0.06
757
6209
(3002582) Erythrocytes [#/volume] in Urine
512
3847
1.48
11.54
4.7
3.1
e6/l
27.5
79.2
1.70
399
2952
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
67
266
2.58
11.50
10.3
5.6
iu/ml
3786.8
186.1
0.46
12
34
(3007853) Bacteria identified in Skin by Aerobe culture
243
1557
1.66
11.04
2.3
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1051
9081
1.45
10.99
3.9
3.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1212
10795
1.49
10.56
4.7
4.1
pmol/l
14.7
14.6
0.22
1128
9940
(3000850) Epithelial cells [#/volume] in Urine
372
2663
1.52
10.46
3.8
2.4
e6/l
5.6
6.8
0.91
334
2346
(3003458) Phosphate [Moles/volume] in Serum or Plasma
241
1581
1.62
9.92
9.7
5.8
mmol/l
1.1
1.0
0.43
231
1468
(3009261) Glucose [Presence] in Urine by Test strip
809
6741
1.40
9.92
4.0
3.5
estimate
0.0
0.0
1.06
131
1243
(3021601) Nitrite [Presence] in Urine by Test strip
801
6674
1.40
9.76
5.6
4.7
estimate
0.0
0.0
0.50
136
1274
(3035350) Ketones [Presence] in Urine by Test strip
797
6638
1.39
9.72
4.0
3.5
estimate
0.0
0.0
0.00
132
1256
(3019550) Sodium [Moles/volume] in Serum or Plasma
1468
13728
1.73
9.54
17.9
14.3
mmol/l
139.7
139.6
0.30
1442
13372
(3031040) Bacteria [#/volume] in Urine by Automated count
1023
8903
1.40
9.52
4.9
4.2
e6/l
3705.1
2377.8
—
9
116
(3021589) Normoblasts [#/volume] in Blood
730
6020
1.39
9.31
12.2
9.0
e9/l
0.0
0.0
0.01
607
4932
(3015377) Calcium [Moles/volume] in Serum or Plasma
552
4358
1.40
9.06
4.4
3.4
mmol/l
2.4
2.4
0.15
485
3853
(3037467) Urinalysis macro (dipstick) panel - Urine
1062
9339
1.40
9.04
5.3
4.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
284
1979
1.53
8.94
5.0
3.5
mmol/l
0.8
0.8
0.03
262
1852
(3023103) Potassium [Moles/volume] in Serum or Plasma
1468
13769
1.70
8.90
18.3
14.4
mmol/l
3.9
3.9
1.58
1442
13387
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
564
4485
1.39
8.82
4.6
3.1
u/l
28.8
30.9
1.34
539
4272
(3026493) Urate [Moles/volume] in Serum or Plasma
431
3276
1.43
8.71
3.7
2.5
umol/l
3336.8
5260.2
0.50
381
2866
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
156
950
1.71
8.53
6.0
3.7
ng/l
101.7
80.8
1.31
144
835
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1370
12670
1.52
8.50
5.6
4.8
mu/l
1.8
2.0
1.03
1288
11749
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
630
5127
1.37
8.47
2.1
1.9
pmol/l
97.6
96.5
0.25
318
2682
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
401
2.07
8.42
2.4
2.4
g/l
9.9
10.4
0.61
73
346
(40768446) Kidney Pathology biopsy report
21
49
4.33
8.41
1.8
1.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
794
6729
1.35
8.12
8.1
6.0
umol/l
11.7
11.2
0.33
755
6376
(3000494) Fungus identified in Specimen by Culture
229
1565
1.54
7.83
1.9
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
312
2273
1.46
7.82
3.8
2.9
mmol/l
2.4
2.4
0.53
271
2011
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
428
1.99
7.74
2.3
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
428
1.99
7.74
2.3
2.4
g/l
7.0
7.4
1.17
67
335
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
428
1.99
7.74
2.3
2.4
g/l
3.9
3.7
0.27
67
320
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
16
32
5.04
7.67
1.0
1.8
ug/l
1.6
1.9
—
7
17
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
83
432
1.97
7.54
2.9
1.6
g/l
1.1
1.2
3.25
78
406
(3022948) Iron [Moles/volume] in Serum or Plasma
275
1969
1.48
7.51
3.6
2.3
umol/l
13.6
13.5
0.08
265
1826
(3003338) MCHC [Mass/volume]
1287
11838
1.42
7.45
21.7
16.4
g/l
332.3
332.5
0.43
1279
11758
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
22
5.95
7.38
5.1
6.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
213
1451
1.54
7.38
1.5
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
269
1925
1.48
7.36
1.5
1.3
titre
488.0
567.3
0.42
50
387
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
89
3.18
7.28
2.1
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
1581
15282
2.37
7.25
24.7
18.9
fl
90.7
90.7
0.05
1568
15092
(3035941) MCH [Entitic mass]
1581
15284
2.36
7.22
24.6
18.9
pg
30.2
30.2
0.07
1568
15091
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1446
13627
1.56
7.20
17.3
12.9
mg/l
21.1
21.9
0.37
1103
10676
(3026361) Erythrocytes [#/volume] in Blood
1581
15285
2.36
7.20
24.8
18.9
e12/l
4.5
4.5
0.32
1554
14903
(3007461) Platelets [#/volume] in Blood
1580
15272
2.34
7.18
24.8
19.0
e9/l
255.8
255.7
0.02
1558
14929
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
315
2334
1.43
7.17
3.8
3.5
ng/l
529.9
489.0
0.04
223
1684
(3010813) Leukocytes [#/volume] in Blood
1581
15288
2.35
7.14
24.8
19.0
e9/l
6.5
6.7
1.83
1555
14904
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
60
283
2.16
7.11
1.6
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
251
1785
1.48
7.07
3.7
2.3
g/l
2.3
2.4
0.95
241
1664
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
73
372
2.01
7.06
2.8
2.6
g/l
0.7
0.9
0.19
66
333
(3000963) Hemoglobin [Mass/volume] in Blood
1581
15293
2.34
7.05
24.9
19.1
g/l
134.7
135.0
0.33
1571
15096
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
234
1646
1.49
6.96
3.9
2.4
%
23.6
23.1
0.23
215
1414
(3020630) Protein [Mass/volume] in Serum or Plasma
147
932
1.63
6.91
2.7
2.9
g/l
66.3
67.0
0.48
141
856
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
77
405
1.95
6.82
2.4
2.4
g/l
3.1
3.1
0.04
67
326
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
213
1482
1.50
6.67
4.5
2.6
umol/l
8.4
7.3
0.42
191
1277
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1513
14453
1.70
6.66
13.3
9.8
u/l
24.8
25.8
1.60
1485
13998
(3026782) Osmolality of Urine
330
2499
1.40
6.60
4.2
2.6
mosm/kgh2o
526.2
544.4
0.88
285
2137
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
55
260
2.15
6.50
1.9
1.4
u/ml
108.9
110.5
0.04
11
48
(3009445) Proteinase 3 Ab [Units/volume] in Serum
92
526
1.79
6.31
2.3
1.4
u/ml
8.1
11.3
—
8
11
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
428
1.86
6.11
1.4
1.4
u/l
11.4
10.2
0.25
64
346
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
135
865
1.61
6.10
1.7
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
76
414
1.88
6.09
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
585
4886
1.31
6.07
9.0
8.3
inr
1.1
1.2
0.86
155
1470
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1504
14399
1.61
5.87
19.3
14.5
umol/l
77.9
73.4
3.73
1504
14394
(3004588) Protein electrophoresis panel - Serum or Plasma
123
780
1.62
5.80
2.5
2.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
125
797
1.62
5.77
2.0
2.1
nmol/l
11.1
12.3
1.00
114
703
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
179
1238
1.50
5.77
2.8
2.3
u/l
34.7
36.7
0.29
159
1052
(3014765) Yersinia sp identified in Stool by Organism specific culture
75
417
1.84
5.66
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
89
524
1.74
5.55
2.5
2.2
s
21.8
21.0
0.57
81
456
(3018677) aPTT in Platelet poor plasma by Coagulation assay
258
1927
1.40
5.53
2.5
2.1
s
29.4
29.5
0.17
250
1864
(3048689) Calprotectin [Mass/mass] in Stool
243
1801
1.41
5.45
2.6
2.3
ug/g
97.7
114.2
0.54
196
1411
(40760892) CBC W Ordered Manual Differential panel - Blood
394
3154
1.33
5.44
5.2
4.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
184
1296
1.47
5.42
3.4
2.0
nmol/l
369.9
377.3
0.23
173
1194
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
8
5
16.07
5.41
5.4
3.0
mg/l
19.4
19.0
—
8
5
(3001122) Ferritin [Mass/volume] in Serum or Plasma
730
6341
1.28
5.41
3.7
2.8
ug/l
107.1
104.3
0.12
680
5902
(42529406) Shigella sp [Presence] in Stool by Culture
75
424
1.81
5.38
1.2
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
48
3.57
5.33
1.2
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1059
9640
1.28
5.30
3.4
3.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1495
14336
1.55
5.28
14.5
12.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
509
4235
1.29
5.27
2.4
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
360
2856
1.33
5.27
1.7
1.5
g/l
2.2
2.3
0.46
223
1765
(3000991) Gas panel - Venous blood
146
990
1.52
5.18
8.1
8.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
14
35
4.03
5.17
6.9
4.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
164
2.29
5.16
1.3
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
152
1042
1.51
5.12
3.4
2.8
g/l
10.1
10.5
0.70
140
953
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
45
3.58
5.05
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1420
13501
1.42
5.04
5.1
4.5
mmol/l
2.8
2.8
0.67
1343
12540
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
33
141
2.37
5.01
6.1
4.2
u/ml
33.2
73.2
0.72
11
38
(3052851) Hemolysis interference index of Serum or Plasma
67
375
1.82
4.98
2.1
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
474
3939
1.29
4.90
2.9
2.9
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
123
816
1.55
4.83
2.4
1.8
g/l
1.4
1.4
0.05
115
752
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1347
12725
1.35
4.75
4.1
3.7
mmol/l
1.2
1.3
2.16
1266
11790
(3005322) IgE [Units/volume] in Serum or Plasma
141
970
1.50
4.68
1.3
1.3
u/ml
156.5
216.1
0.70
133
895
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
391
3185
1.30
4.68
2.4
2.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
178
2.16
4.68
2.9
2.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
846
7561
1.25
4.65
5.5
4.7
mmol/l
6.5
6.6
1.10
789
7020
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
728
6398
1.25
4.64
4.1
3.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
53
3.23
4.62
1.3
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
53
3.23
4.62
1.3
2.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
81
2.74
4.52
8.6
6.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
8
10.04
4.52
2.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
97
620
1.60
4.48
6.1
4.1
mmol/l
24.0
24.1
0.07
90
565
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
93
2.60
4.48
2.4
2.7
%
12.9
12.8
0.02
15
53
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
133
913
1.50
4.47
3.8
3.3
pmol/l
4.5
4.5
0.01
122
806
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
449
3747
1.27
4.42
2.2
2.1
u/l
186.3
217.1
0.35
418
3545
(4010399)
134
925
1.49
4.39
1.5
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
150
2.22
4.38
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
64
370
1.76
4.32
2.9
2.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
143
1005
1.46
4.29
2.8
2.4
ml/min/173m2
63.6
69.2
0.75
58
396
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
44
227
1.96
4.23
5.5
2.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
24
96
2.52
4.22
1.1
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
339
2746
1.30
4.19
1.5
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
121
827
1.50
4.17
1.3
1.4
iu/l
23.0
27.3
0.81
102
703
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
81
507
1.63
4.10
2.7
2.0
g/l
1.2
1.5
1.70
74
444
(3023420) DNA double strand Ab [Units/volume] in Serum
33
155
2.15
4.07
3.4
1.6
iu/ml
60.5
26.8
—
6
9
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
69
415
1.69
4.07
3.5
1.6
g/l
0.2
0.2
1.89
64
391
(3042936) Bacteria identified in Isolate by Culture
237
1834
1.34
4.05
2.2
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
182
1356
1.39
3.96
1.8
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
248
1945
1.32
3.87
1.9
1.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
394
3287
1.26
3.82
2.5
2.1
mg/l
2.8
2.9
0.70
343
2807
(3002032) Base excess in Venous blood by calculation
153
1114
1.41
3.81
5.7
3.7
mmol/l
1.5
1.9
0.79
135
896
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1391
13296
1.32
3.80
4.6
4.1
mmol/l
4.7
4.7
0.37
1322
12423
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
40
208
1.95
3.79
1.1
1.1
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
5
12.04
3.76
1.8
1.4
mg/l
6.7
4.6
—
6
5
(3019150) Specific gravity of Urine by Refractometry
351
2894
1.27
3.75
3.9
3.8
kg/l
1.0
1.0
0.07
46
421
(3017817) Protein [Mass] in Urine collected for unspecified duration
24
102
2.37
3.75
3.2
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1384
13228
1.32
3.72
4.5
4.1
mmol/l
1.5
1.5
1.38
1315
12295
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
101
682
1.51
3.71
1.6
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1335
12701
1.29
3.70
15.8
11.5
ml/min/173m2
82.5
84.8
2.95
1095
10381
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
59
350
1.71
3.68
1.6
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
16
5.65
3.66
3.2
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
41
218
1.90
3.65
1.8
1.6
g/l
0.6
0.8
0.38
32
163
(3012544) pH of Venous blood
156
1149
1.40
3.64
5.4
3.8
—
7.4
—
0
5
(3023368) Bacteria identified in Blood by Culture
385
3225
1.25
3.58
5.1
4.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
95
639
1.52
3.57
2.4
2.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
92
2.41
3.56
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
392
3295
1.25
3.53
1.4
1.3
u/ml
1.1
1.5
0.44
111
869
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
586
5141
1.22
3.53
4.1
3.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
417
3531
1.24
3.52
1.7
1.6
mmol/l
1.4
1.4
0.04
377
3016
(3009542) Hematocrit [Volume Fraction] of Blood
1344
12817
1.28
3.52
18.9
13.8
%
40.0
39.8
0.62
1051
9692
(3021447) Carbon dioxide [Partial pressure] in Venous blood
152
1123
1.39
3.49
5.4
3.7
kpa
5.9
5.8
0.36
146
1088
(40761535) Cells panel - Urine sediment
138
1003
1.41
3.49
3.4
3.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
173
1308
1.36
3.45
3.5
2.8
%
1.6
1.8
2.85
163
1172
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
472
4058
1.23
3.45
3.7
2.5
u/l
56.5
56.3
0.04
435
3751
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
180
1372
1.35
3.41
1.9
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
194
1497
1.34
3.39
6.3
6.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
74
477
1.58
3.37
1.8
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
50
291
1.74
3.36
1.5
1.3
u/ml
293.0
244.6
0.41
37
172
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
279
2266
1.28
3.35
4.7
4.2
%
25.1
20.9
3.21
130
1055
(3025941) Bacteria identified in Stool by Culture
110
775
1.45
3.31
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1352
12927
1.28
3.30
4.6
4.2
mmol/l
5.8
5.8
0.80
1269
11871
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
147
1092
1.38
3.28
1.3
1.2
iu/ml
104.9
140.5
0.74
54
422
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
52
310
1.70
3.23
1.5
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
15
5.35
3.19
2.1
1.3
ng/l
192.1
79.1
—
8
15
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
15
5.35
3.19
1.9
4.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
430
1.58
3.13
1.4
1.6
iu/ml
0.7
0.2
0.33
15
79
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
18
73
2.48
3.13
1.6
1.1
u/l
100.1
79.3
0.50
18
65
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
67
2.55
3.13
1.2
1.1
miu/ml
1583.8
1638.6
0.06
17
67
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
160
1215
1.35
3.12
3.8
4.3
ug/l
3.3
22.4
2.06
128
989
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
50
2.82
3.09
3.4
2.0
ug/l
68.9
70.9
0.02
14
50
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
247
1.76
3.05
2.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
53
324
1.66
3.02
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
33
175
1.90
3.01
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
136
1014
1.37
2.99
1.6
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
294
2438
1.25
2.96
1.3
1.3
iu/ml
40.0
30.2
0.24
89
767
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
63
406
1.57
2.91
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
22
102
2.17
2.87
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1267
12079
1.22
2.85
5.7
5.3
mmol/mol
38.6
39.2
1.48
1189
11272
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
280
2322
1.25
2.82
1.3
1.3
u/ml
10.0
11.2
0.11
96
925
(3017143) Hepatitis C virus Ab [Presence] in Serum
222
1792
1.28
2.80
1.9
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
125
930
1.37
2.80
2.2
2.3
ug/l
6.5
7.0
0.12
107
823
(3011412) CD3 cells [#/volume] in Blood
25
124
2.03
2.76
2.9
2.6
e9/l
1.1
1.1
0.14
19
77
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
373
3195
1.22
2.76
3.1
2.9
ng/l
1406.1
1143.0
0.51
311
2671
(3015171) Extractable nuclear Ab [Units/volume] in Serum
81
559
1.47
2.75
1.3
1.2
u/ml
0.2
1.3
—
7
42
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
36
203
1.79
2.74
1.2
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
264
2184
1.25
2.71
1.7
1.7
nmol/l
1192.0
1187.2
0.03
201
1656
(3004716) Salmonella sp identified in Stool by Organism specific culture
112
823
1.39
2.71
1.4
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
127
954
1.36
2.69
3.8
2.8
e9/l
65.1
72.9
2.10
92
727
(46235355) HIV 1 and 2 tests - Meaningful Use set
364
3120
1.21
2.67
2.0
1.9
—
—
—
0
0
(4034850)
22
428
0.51
2.65
5.0
9.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
85
597
1.45
2.65
1.8
2.0
u/l
39.9
39.6
0.05
72
536
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
243
1.71
2.65
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
243
1.71
2.65
1.3
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
333
2835
1.22
2.62
5.2
4.9
ug/l
2.0
2.4
1.00
305
2547
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
58
377
1.56
2.61
1.6
2.1
mg/l
11.4
11.6
0.08
53
349
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
80
2.26
2.61
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
43
260
1.67
2.59
3.8
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
60
398
1.53
2.49
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
39
2.83
2.47
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
19
89
2.15
2.45
1.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
13
51
2.56
2.44
1.2
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
136
1050
1.32
2.42
6.4
7.4
mmol/l
1.2
1.4
1.79
130
1004
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
117
1.98
2.41
6.1
3.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
71
492
1.46
2.40
1.5
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
204
1663
1.26
2.39
3.4
3.0
ug/l
0.7
0.7
0.44
149
1076
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
44
274
1.62
2.39
4.4
3.8
%
59.1
57.3
0.56
44
274
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
104
2.03
2.36
1.9
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
132
1.91
2.36
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
161
1277
1.29
2.36
1.8
1.9
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
64
436
1.49
2.36
4.3
3.5
u/ml
111.1
987.3
1.29
50
375
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
331
1.56
2.34
4.0
3.8
mg/l
71.4
66.6
0.04
38
265
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
331
1.56
2.34
4.0
3.8
mg/l
31.6
40.6
0.37
38
266
(3011648) Oxygen content in Venous blood
19
91
2.10
2.33
2.8
4.3
%
11.7
10.7
0.45
19
91
(21494890) Protein electrophoresis panel - 24 hour Urine
22
112
1.98
2.31
2.4
2.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
35
2.87
2.30
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
72
2.23
2.28
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
79
565
1.42
2.27
1.7
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
47
2.56
2.27
2.5
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
52
342
1.54
2.26
3.2
3.3
u/ml
0.3
0.4
2.15
28
183
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
21
106
1.99
2.26
2.9
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
194
1.72
2.23
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
147
1162
1.29
2.22
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
81
585
1.40
2.21
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
981
9233
1.16
2.20
3.7
3.0
u/l
41.4
43.1
0.35
927
8704
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
36
2.79
2.20
1.2
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
42
265
1.60
2.19
4.0
3.6
e9/l
3.9
4.1
0.28
42
265
(3016502) Oxygen saturation in Arterial blood
147
1167
1.29
2.15
5.8
9.2
%
96.4
95.7
0.71
140
1129
(3013139) Helicobacter pylori Ag [Presence] in Stool
118
911
1.32
2.13
1.2
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
34
205
1.67
2.12
1.4
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
11
43
2.57
2.09
1.3
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
120
935
1.31
2.04
4.5
3.1
kpa
4.7
4.7
0.19
115
905
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
223
1.63
2.03
2.1
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
222
1863
1.22
2.02
1.4
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
162
1314
1.26
2.01
5.8
8.6
mmol/l
0.5
1.1
1.19
126
1036
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
38
2.64
2.01
1.2
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
20
104
1.93
2.00
2.0
1.6
g/l
1.0
1.0
0.02
20
104
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
355
3114
1.18
2.00
2.3
1.7
mg/l
0.9
1.1
1.01
258
2368
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
334
2916
1.18
1.99
1.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
331
2890
1.18
1.97
1.5
1.5
nmol/l
22.0
20.7
0.78
283
2474
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
123
967
1.29
1.96
2.6
2.4
au/ml
24.0
19.3
—
7
58
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
96
729
1.34
1.96
1.6
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
210
1.63
1.95
1.5
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
94
713
1.34
1.93
2.3
2.2
u/l
5437.3
4730.9
0.08
37
294
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
27
2.97
1.93
2.5
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
27
2.97
1.93
2.6
1.1
%
75.9
101.3
—
8
27
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
16
3.76
1.93
1.3
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
33
2.74
1.93
1.2
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
219
1.61
1.92
1.1
1.0
u/ml
2.4
1.8
0.23
20
97
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
161
1316
1.25
1.88
5.8
8.6
kpa
4.9
5.1
1.54
152
1260
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
112
877
1.30
1.85
1.4
1.3
au/ml
88.7
35.7
—
5
48
(3024932) HLA-DR beta [Type]
10
40
2.51
1.83
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
58
410
1.43
1.83
1.1
1.1
u/ml
3.2
5.2
0.27
11
54
(3025130) Human papilloma virus identified in Specimen
36
231
1.57
1.79
1.8
1.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
92
705
1.32
1.79
7.6
10.3
%
94.3
93.9
0.25
92
700
(3027801) Oxygen [Partial pressure] in Arterial blood
160
1316
1.24
1.78
5.8
8.6
kpa
12.7
12.4
0.26
151
1263
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
47
2.35
1.78
2.6
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
399
3565
1.16
1.77
4.5
3.8
estimate
0.0
0.0
1.28
133
1247
(3024471) HLA-A [Type]
10
41
2.45
1.75
1.0
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
134
1082
1.26
1.75
6.2
9.5
g/l
118.5
121.8
0.95
129
1045
(3016018) Differential panel - Cerebral spinal fluid
25
147
1.71
1.74
1.3
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
24
2.92
1.72
1.3
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
13
3.85
1.71
3.6
4.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
89
1.92
1.70
1.6
2.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
54
383
1.42
1.69
1.5
2.0
iu/l
2.6
5.1
3.96
11
142
(3009508) Creatinine [Moles/volume] in Urine
433
3907
1.15
1.67
4.3
3.3
mmol/l
7.1
7.6
1.17
381
3318
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
40
268
1.50
1.67
1.4
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
76
1.98
1.64
1.1
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
32
2.51
1.59
3.0
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
38
255
1.50
1.58
1.1
1.1
au/ml
5.3
10.4
—
5
17
(3051611) Lipemic interference index of Serum or Plasma
21
121
1.75
1.58
2.4
2.9
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
20
3.01
1.58
1.3
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
77
590
1.32
1.53
1.5
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
51
366
1.41
1.52
1.5
1.2
—
1094.2
—
0
12
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
27
169
1.61
1.52
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
225
1.52
1.52
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
177
1.59
1.52
1.9
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
77
591
1.32
1.52
7.3
10.9
mmol/l
24.1
24.3
0.24
71
558
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
21
2.86
1.50
1.3
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
43
300
1.45
1.50
2.9
4.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
18
101
1.79
1.49
1.4
1.1
iu/ml
13.4
12.7
—
6
26
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
186
1.57
1.49
2.5
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
38
2.38
1.45
1.2
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
244
1.49
1.45
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
168
1422
1.20
1.44
30.9
22.2
inr
1.6
1.3
1.00
25
205
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
71
543
1.32
1.44
1.6
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
17
95
1.80
1.43
1.5
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
387
3502
1.14
1.42
4.6
3.3
mg/l
913.3
327.5
0.88
253
2224
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
141
1.64
1.42
1.8
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
149
1.62
1.41
2.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
24
150
1.61
1.38
1.1
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
60
2.01
1.38
3.6
2.8
u/ml
570.3
938.3
0.83
12
60
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
23
2.61
1.37
1.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
49
358
1.38
1.35
1.4
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
17
97
1.76
1.35
1.2
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
324
1.40
1.35
1.4
1.6
e6/l
20.6
12.3
0.22
34
250
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
324
1.40
1.35
1.4
1.7
e6/l
223.6
722.4
0.58
35
259
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
37
0.00
1.34
0.0
1.2
—
56.8
—
0
28
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
14
75
1.87
1.34
2.1
1.7
u/field
2.8
2.7
—
9
56
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
110
900
1.24
1.33
2.9
2.8
ng/l
127.2
166.2
1.28
104
816
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
90
1.79
1.33
1.9
1.5
u/l
2.4
8.7
—
8
42
(1616796) Gas panel - Central venous blood
37
258
1.44
1.32
3.8
3.5
—
—
—
0
0
(44806118)
25
160
1.57
1.32
2.2
1.6
—
—
—
0
0
(44790047)
25
160
1.57
1.32
2.2
1.6
—
—
—
0
0
(44790048)
25
160
1.57
1.32
2.2
1.6
—
—
—
0
0
(44790049)
25
160
1.57
1.32
2.2
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
33
225
1.48
1.31
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
404
3685
1.13
1.31
5.3
4.0
mg/mmol
11.0
9.3
0.35
263
2308
(40768795) Lymph node Pathology biopsy report
20
121
1.66
1.31
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
48
352
1.37
1.30
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
41
293
1.41
1.29
1.2
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
91
1.77
1.29
1.8
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
24
154
1.57
1.26
1.2
1.3
nmol/l
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
92
1.75
1.25
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
61
468
1.32
1.25
1.5
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
6
25
2.41
1.24
3.0
2.8
u/l
307.5
3486.9
—
6
25
(3025577) Chromium [Mass/volume] in Blood
12
63
1.91
1.23
2.5
2.1
ug/l
2.1
1.9
0.07
12
54
(3049717) Cytology report of Urine Cyto stain
54
409
1.33
1.21
2.1
2.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
93
1.73
1.21
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
35
247
1.43
1.19
4.4
4.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
52
393
1.33
1.19
1.6
1.5
ug/g
247.5
291.7
0.84
28
225
(3026470) Cobalt [Mass/volume] in Blood
12
64
1.88
1.18
2.6
2.1
ug/l
3.5
3.2
0.08
12
56
(4306422)
32
223
1.44
1.17
1.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
190
1.48
1.16
1.9
1.6
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
33
0.00
1.16
0.0
1.2
—
87.9
—
0
26
(3051593) INR in Capillary blood by Coagulation assay
8
39
2.06
1.15
3.6
12.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
66
519
1.28
1.14
4.2
4.2
mmol/l
24.4
24.9
0.81
61
490
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
126
1.59
1.14
1.8
1.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
36
0.00
1.14
0.0
1.1
—
29.8
—
0
30
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
36
0.00
1.14
0.0
1.2
—
3.9
—
0
28
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
33
233
1.42
1.13
1.4
1.2
u/ml
2.1
5.5
1.46
15
93
(3037756) Immunofixation for Serum or Plasma
34
242
1.41
1.12
1.7
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
43
572
0.74
1.12
2.2
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
118
994
1.20
1.11
5.7
4.3
%
0.0
0.5
0.63
28
239
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
37
268
1.39
1.11
1.6
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
31
2.26
1.10
1.3
1.1
u/ml
46.4
37.5
—
7
31
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
128
1.57
1.08
1.3
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
287
2595
1.13
1.08
1.8
1.7
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
32
2.19
1.08
1.0
1.2
—
72.6
—
0
8
(3000475) Leukocytes [#/volume] in Synovial fluid
40
296
1.36
1.06
2.2
1.8
e6/l
7419.0
14044.5
0.94
27
222
(4062490)
21
137
1.54
1.06
1.5
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
113
1.60
1.05
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
113
1.60
1.05
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
113
1.60
1.05
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
288
1.36
1.05
3.5
2.4
ug/min
69.4
91.9
0.30
28
177
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
33
2.13
1.05
2.0
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
96
798
1.22
1.05
4.1
3.8
kpa
5.1
5.2
0.30
86
757
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
67
1.80
1.04
1.1
1.3
—
75.0
—
0
12
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
229
1.41
1.04
1.9
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
146
1.51
1.03
1.4
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
114
1.59
1.02
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
114
1.59
1.02
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
114
1.59
1.02
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
123
1050
1.19
1.02
5.7
4.3
%
0.3
0.1
0.67
32
280
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
195
1728
1.15
1.01
1.7
1.8
%
1.4
1.4
1.41
171
1538
(3017181) Myelocytes/100 leukocytes in Blood
128
1099
1.18
1.00
5.6
4.2
%
1.1
0.9
0.37
33
304
(3010726) Horse dander IgE Ab [Units/volume] in Serum
38
283
1.35
0.99
1.0
1.1
u/ml
1.0
2.2
—
9
73
(3002619) Bacteria identified in Specimen by Culture
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
41
310
1.33
0.97
2.1
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
50
1.80
0.96
1.3
1.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
23
157
1.47
0.96
1.4
1.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
330
1.31
0.93
1.0
1.1
u/ml
5.1
1.7
0.39
16
130
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
278
1.34
0.92
1.7
1.4
nmol/l
0.4
0.4
0.14
28
227
(3047007) Chlamydophila sp Ab [Presence] in Serum
31
227
1.37
0.91
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
137
1566
0.86
0.90
4.5
4.2
%
31.9
32.4
0.21
103
1082
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
314
1.31
0.90
2.0
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
26
185
1.41
0.89
3.4
2.3
u/ml
41.7
26.5
0.14
26
170
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
492
4624
1.09
0.89
3.6
3.3
ng/l
28.6
43.5
0.91
288
2922
(3032057) Clostridioides difficile [Presence] in Stool
6
29
2.07
0.89
1.3
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
130
1487
0.86
0.87
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
107
1242
0.85
0.87
6.9
3.8
—
—
—
0
0
(3009343) pH of Capillary blood
93
789
1.19
0.86
4.2
3.8
ph
7.4
7.4
—
10
101
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
120
1.51
0.85
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
74
615
1.21
0.85
6.6
12.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
45
1.78
0.84
1.5
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
328
1.29
0.82
1.7
1.5
—
—
—
0
0
(3012565) Volume of 24 hour Urine
11
65
1.70
0.82
2.4
3.0
ml
1555.5
1968.3
0.76
11
60
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
765
1.19
0.82
4.2
3.8
mmol/l
1.3
1.7
0.50
67
575
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
37
284
1.31
0.82
1.6
1.4
—
—
—
0
0
(4133840)
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
32
1.88
0.82
1.3
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
398
3721
1.09
0.81
3.7
3.1
—
—
—
0
0
(3000492) Spirometry study
151
1339
1.14
0.80
1.8
1.4
—
—
—
0
0
(4268621)
22
157
1.41
0.76
2.5
2.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
46
368
1.26
0.76
1.5
1.2
u/ml
15.5
2.8
—
6
38
(44806420)
0
28
0.00
0.76
0.0
2.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
70
587
1.20
0.75
1.8
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
20
141
1.42
0.74
1.2
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
9
54
1.67
0.74
1.4
1.1
%
112.7
112.3
—
9
44
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
108
1.49
0.73
1.6
1.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
25
2.00
0.72
1.0
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
47
380
1.24
0.72
1.4
1.4
pmol/l
81.2
167.7
1.03
47
374
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
76
1.58
0.71
1.5
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
151
1.40
0.71
1.3
1.4
pmol/l
477.7
334.4
0.54
15
114
(21494814) CD8 cells/100 lymphocytes in Specimen
7
40
1.75
0.71
3.0
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
65
546
1.20
0.70
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
85
1.53
0.69
1.6
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
77
1.56
0.68
2.1
3.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
69
1.60
0.68
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
374
1.24
0.68
1.5
1.2
u/ml
3.9
12.3
—
8
63
(4094501)
40
320
1.26
0.68
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
114
1006
1.14
0.68
5.0
4.0
%
0.6
0.5
0.19
26
226
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
127
1.42
0.68
1.1
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
94
1.49
0.66
1.6
1.3
e6/l
91737.5
108208.1
—
8
50
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
241
1.29
0.66
1.3
1.2
u/ml
7.1
3.6
—
8
72
(3006653) Thiamine [Moles/volume] in Blood
10
62
1.62
0.65
1.0
1.5
nmol/l
151.0
144.2
—
10
62
(3008152) Bicarbonate [Moles/volume] in Arterial blood
84
729
1.16
0.64
6.5
8.1
mmol/l
24.1
24.7
0.87
78
681
(3021879) Hepatitis B virus core Ab [Presence] in Serum
129
1155
1.13
0.63
1.5
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
57
479
1.20
0.63
1.7
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
68
581
1.18
0.63
4.2
3.9
—
—
—
0
0
(4027681)
15
104
1.45
0.62
1.3
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
49
1.64
0.62
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
52
434
1.20
0.62
1.5
1.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
10
63
1.59
0.61
3.8
1.6
—
38.8
—
0
7
(3011897) Casein IgE Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.2
—
2.3
—
0
6
(3028433) Virus identified in Specimen by Culture
8
50
1.60
0.61
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
27
209
1.30
0.60
1.6
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
105
1.43
0.60
1.6
1.6
%
23.6
32.0
—
10
69
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
30
236
1.28
0.60
1.6
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
299
1.24
0.60
1.4
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
10
64
1.57
0.58
1.6
1.4
u/l
11.0
13.8
—
10
58
(3047352) Trisomy 18 risk [Likelihood] in Fetus
35
431
0.81
0.58
1.3
1.4
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
4.3
—
1.4
—
0
16
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
81
1.49
0.57
1.2
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
34
274
1.25
0.57
3.1
4.0
mmol/l
2.2
2.6
0.49
25
183
(3000330) Specific gravity of Urine by Test strip
72
625
1.16
0.56
3.0
3.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
35
428
0.81
0.55
1.3
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
65
1.54
0.55
1.6
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
482
5034
0.94
0.54
2.7
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
36
438
0.82
0.54
1.4
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
99
1.42
0.54
1.3
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
61
1.48
0.53
1.8
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
91
1.43
0.53
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
24
304
0.79
0.52
1.9
2.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
26
206
1.27
0.51
1.2
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
45
529
0.85
0.49
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
107
966
1.12
0.49
2.3
2.6
e9/l
4.6
4.1
0.57
81
782
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
45
1.56
0.49
2.4
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
45
1.56
0.49
2.4
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
65
568
1.15
0.48
1.3
1.3
miu/ml
249.5
234.6
0.13
36
283
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
45
528
0.85
0.48
1.4
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
46
1.52
0.48
2.4
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
45
527
0.85
0.47
1.4
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
47
1.49
0.47
1.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
49
569
0.86
0.47
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
45
526
0.85
0.46
1.4
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
33
273
1.21
0.46
2.4
2.3
g/l
129.9
129.9
0.00
20
207
(3050129) First trimester maternal screen panel - Serum or Plasma
73
647
1.13
0.45
1.5
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
77
1.43
0.45
1.3
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
77
1.43
0.45
1.3
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
103
1.36
0.45
2.2
2.2
u/field
2.0
2.1
—
6
47
(3035933) Granulocytes/100 leukocytes in Blood
7
50
1.40
0.45
1.4
1.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
22
174
1.27
0.45
1.4
1.3
nmol/l
0.6
0.6
0.10
22
164
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
12
86
1.40
0.44
1.3
1.4
—
1.4
—
0
5
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
57
498
1.15
0.44
4.8
3.4
%
51.5
48.2
0.42
57
492
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
88
792
1.12
0.44
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
31
1.61
0.43
1.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
95
0.63
0.42
1.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
158
1.27
0.42
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
84
757
1.12
0.41
4.0
6.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
2.3
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
2.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
2.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
58
1.38
0.41
2.3
1.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
33
1.52
0.41
1.2
1.3
%
63.6
49.6
—
5
28
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
231
1.22
0.41
1.1
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
105
1.34
0.41
2.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
105
1.34
0.41
2.2
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
105
1.34
0.41
2.2
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
18
0.00
0.40
0.0
2.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
25
205
1.22
0.39
3.6
3.0
nmol/l
0.8
0.8
0.33
19
162
(3023199) Leukocytes [#/volume] in Pleural fluid
14
106
1.32
0.39
1.6
1.3
e6/l
2560.1
1938.5
—
8
72
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
124
1.29
0.38
1.4
1.3
u/ml
1.1
0.8
—
9
50
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
37
1.35
0.37
1.2
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
200
1888
1.07
0.36
2.0
2.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
244
1.19
0.36
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
28
235
1.19
0.36
1.2
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
77
0.65
0.35
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
51
451
1.14
0.35
6.2
4.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
162
1.24
0.35
1.5
1.3
—
—
—
0
0
(3013512) EKG study
370
3561
1.05
0.35
3.7
3.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
44
1.36
0.34
1.0
2.2
—
88522.6
—
0
5
(3029396) Erythrocyte agglutination [Presence] in Blood
6
44
1.36
0.34
3.7
3.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
46
1.31
0.33
2.0
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
87
0.69
0.33
4.2
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
81
884
0.91
0.32
2.5
2.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
26
306
0.85
0.32
2.3
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
83
1.33
0.32
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
277
2655
1.05
0.31
1.7
1.7
pmol/l
21519447.9
33841073.1
0.22
237
2234
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
52
1.35
0.31
1.1
1.1
—
—
—
0
0
(4146454)
10
131
0.76
0.31
2.7
2.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
102
1.28
0.30
1.2
1.1
u/l
0.9
1.1
—
5
49
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
220
2100
1.06
0.30
2.2
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.3
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
44
392
1.13
0.29
1.1
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
107
0.75
0.29
1.0
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
57
1.23
0.29
4.7
2.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
57
1.23
0.29
2.4
2.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
298
1.14
0.28
2.6
2.8
mmol/l
24.9
25.0
0.05
25
268
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
76
1.32
0.28
1.1
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
62
1.29
0.28
2.3
2.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
64
1.25
0.27
1.5
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
64
1.25
0.27
1.1
2.0
—
—
—
0
0
(4211845)
8
64
1.25
0.27
4.3
2.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
50
452
1.11
0.27
3.0
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
300
1.14
0.26
1.1
1.1
u/ml
5.5
6.4
0.11
19
157
(4024509)
13
104
1.25
0.26
1.7
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
283
1.13
0.24
1.4
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
276
0.87
0.24
2.3
3.4
mg/l
11.9
24.3
3.05
13
172
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
155
1626
0.95
0.24
1.5
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
246
1.14
0.23
1.0
1.0
u/ml
4.1
3.8
0.04
11
93
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
115
1.22
0.23
1.3
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
209
1.15
0.23
1.3
1.4
mmol/l
6.2
7.4
1.07
16
146
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
19
162
1.17
0.23
1.7
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
174
1667
1.05
0.22
1.6
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
40
1.25
0.22
5.0
4.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
40
1.25
0.22
2.2
2.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
28
248
1.13
0.21
2.0
1.4
u/l
35.2
24.2
0.67
23
209
(44813793)
13
107
1.22
0.21
1.1
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
6.9
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(4212803)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
102
0.78
0.21
1.3
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
32
287
1.12
0.21
1.0
1.1
u/ml
0.5
1.5
1.06
15
122
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
40
439
0.91
0.21
1.6
1.7
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
10.0
—
0
6
(3009015) Lactate [Moles/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.2
—
6.5
—
0
9
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
155
1.16
0.20
1.8
1.8
%
55.0
57.9
—
10
108
(3021901) Oxygen saturation in Capillary blood
24
212
1.13
0.19
2.7
2.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
165
0.85
0.19
3.2
2.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
1.3
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
52
1.15
0.19
1.0
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
28
251
1.12
0.18
1.3
1.3
ug/l
2.9
2.9
0.03
23
229
(40765089) Chromosome analysis panel - Blood by G-banded
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
11
91
1.21
0.17
1.1
1.5
—
1950.5
—
0
17
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
157
1.15
0.17
1.5
2.3
mg/l
30.0
27.7
—
6
40
(3024263) Appearance of Synovial fluid
7
62
1.13
0.17
5.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
62
1.13
0.17
1.1
1.1
iu/ml
110.9
208.0
—
7
62
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
63
1.11
0.17
1.3
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
5
70
0.71
0.16
1.4
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.3
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
114
1188
0.96
0.16
5.8
3.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
92
964
0.95
0.16
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
78
0.77
0.15
1.7
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
159
1.13
0.15
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
159
1.13
0.15
1.8
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
159
1.13
0.15
1.8
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
140
1.14
0.15
1.4
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
265
1.10
0.14
1.4
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
95
991
0.96
0.14
1.5
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
227
1.10
0.14
1.6
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
160
1.13
0.14
1.8
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
10
84
1.19
0.14
1.3
1.3
umol/l
26.3
24.9
—
10
77
(3037121) Protein [Mass/volume] in Urine
47
441
1.07
0.13
3.1
3.6
g/l
0.2
0.3
0.21
20
185
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
132
1279
1.03
0.12
3.6
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
410
4039
1.02
0.12
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
42
395
1.06
0.12
1.5
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
162
1.11
0.12
1.8
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
114
1.14
0.11
2.3
2.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
27
250
1.08
0.11
3.5
2.9
mmol/l
1.4
1.5
0.52
27
244
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
105
1017
1.03
0.10
6.4
3.5
mmol/l
1.2
1.2
0.28
93
884
(3039443) Prostate specific Ag panel - Serum or Plasma
17
187
0.91
0.10
1.4
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
21
193
1.09
0.10
1.7
1.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
25
232
1.08
0.09
3.7
3.0
mmol/l
6.8
7.5
0.53
25
227
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
174
1.09
0.09
1.4
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
126
1.11
0.09
1.2
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
22
237
0.93
0.09
2.6
1.9
umol/l
7.6
5.4
0.37
17
170
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
165
0.91
0.09
1.1
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
64
1.09
0.08
1.3
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
64
1.09
0.08
2.4
3.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
84
0.83
0.07
1.3
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
92
0.87
0.06
1.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
132
0.91
0.06
2.8
2.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
101
0.89
0.06
2.0
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
100
0.90
0.06
2.4
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
111
0.90
0.06
1.8
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
15
139
1.08
0.05
1.1
1.6
mosm/kgh2o
281.2
282.3
—
10
106
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
19
202
0.94
0.05
1.2
1.2
u/l
26.2
28.1
0.05
12
174
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
62
604
1.03
0.05
1.5
1.7
mg/l
3.0
4.2
0.52
37
422
(40768800) Prostate Pathology biopsy report
17
181
0.94
0.05
1.5
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
141
1390
1.02
0.04
1.8
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
46
474
0.97
0.04
1.6
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
43
417
1.03
0.04
5.0
3.9
mmol/l
1.2
1.4
0.89
43
410
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
17
160
1.06
0.04
2.4
2.0
pg
31.5
32.4
0.36
17
160
(4281824)
16
151
1.06
0.03
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
47
459
1.02
0.03
1.7
2.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
25
241
1.04
0.02
1.3
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
30
291
1.03
0.02
3.1
2.2
nmol/l
0.8
0.9
0.40
23
242
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
38
371
1.02
0.02
1.4
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
21
202
1.04
0.02
1.5
1.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
11
103
1.07
0.02
17.4
13.9
nmol/l
895.3
830.2
0.17
11
98
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
117
0.94
0.01
1.5
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
38
388
0.98
0.01
3.7
8.5
mmol/l
1.2
1.3
0.28
31
336
(3023419) Bacteria identified in Sputum by Culture
15
157
0.95
0.01
2.8
2.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
183
1820
1.01
0.01
1.7
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
53
522
1.02
0.01
1.6
2.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
11
116
0.95
0.00
1.7
1.4
nmol/l
1.5
1.4
0.07
11
103
(3004616) Nuclear Ab [Presence] in Serum
17
164
1.04
0.00
1.8
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
26
254
1.02
0.00
2.8
4.0
u/ml
24.3
32.4
0.44
26
246
(3023430) Cat dander IgE Ab [Units/volume] in Serum
22
224
0.98
0.00
1.0
1.1
u/ml
11.7
5.3
—
10
92
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
98
1.02
0.00
1.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
122
0.98
0.00
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
524
0.99
0.00
2.1
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
138
1.01
0.00
3.5
2.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
142
0.99
0.00
1.1
1.5
mmol/l
8.5
12.5
—
6
29
(3003740) Influenza virus B Ag [Presence] in Specimen
26
258
1.01
0.00
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
262
0.99
0.00
2.9
2.4
%
15.7
16.3
0.28
14
131
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
12
119
1.01
0.00
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
66
658
1.00
0.00
1.5
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
89
892
1.00
0.00
1.6
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
61
609
1.00
0.00
1.5
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
649
1.00
0.00
1.5
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
107
1.03
0.00
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
66
655
1.01
0.00
1.5
2.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
135
0.96
0.00
4.9
3.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
11
105
1.05
0.00
1.8
1.1
—
43.2
—
0
5
(4198724)
6
66
0.91
0.00
1.3
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
60
1.00
0.00
5.0
3.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
56
0.89
0.00
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
5
56
0.89
0.00
1.2
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
9
93
0.97
0.00
2.9
1.7
mg/l
3.1
3.8
—
9
88
(3000764) Benzodiazepines [Presence] in Urine
65
650
1.00
0.00
1.5
2.1
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
2.5
—
0
6
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
260
1.00
0.00
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
86
0.93
0.00
1.5
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
7.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
65
0.92
0.00
1.0
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
70
1.00
0.00
1.3
1.5
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
13.7
—
0
8
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MELANOCYTIC_LOWERLIMB and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_LOWERLIMB | 1.071 [0.91, 1.27] | 0.422 |
| Birth year | 0.999 [0.99, 1.01] | 0.838 |
During the follow-up period (1.1.1998 — 31.12.2019), 287 out of 5208 females with CD2_BENIGN_MELANOCYTIC_LOWERLIMB died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_LOWERLIMB | 0.987 [0.82, 1.19] | 0.889 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 228 out of 2989 males with CD2_BENIGN_MELANOCYTIC_LOWERLIMB died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MELANOCYTIC_LOWERLIMB.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.098% | 0.19% |
| 5 | 0.626% | 1.261% |
| 10 | 1.676% | 2.956% |
| 15 | 3.351% | 5.426% |
| 20 | 6.121% | 9.002% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_LOWERLIMB – Melanocytic naevi of lower limb, including hip
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data